Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|April 27, 2005
Statins downregulate myeloperoxidase gene expression in macrophagesAlan P Kumar, Wanda F ReynoldsThe Journal of Biological Chemistry|December 12, 2003
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphismAlan P Kumar, F Javier Piedrafita, Wanda F ReynoldsBiochemical and Biophysical Research Communications|September 8, 2006
The human myeloperoxidase gene is regulated by LXR and PPARalpha ligandsWanda F Reynolds, Alan P Kumar, F Javier PiedrafitaNitric Oxide : Biology and Chemistry|May 17, 2005
Inducible nitric oxide synthase expression is inhibited by myeloperoxidaseAlan P Kumar, Colm Ryan, Victoria Cordy, et al.Antioxidants (Basel, Switzerland)|December 23, 2022
Thiocyanate Reduces Motor Impairment in the hMPO-A53T PD Mouse Model While Reducing MPO-Oxidation of Alpha Synuclein in Enlarged LYVE1/AQP4 Positive Periventricular Glymphatic VesselsWanda F Reynolds, Ernst Malle, Richard A MakiClinical Immunology (Orlando, Fla.)|May 25, 2002
-463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitisWanda F Reynolds, Coen A Stegeman, Jan W Cohen TervaertPlos One|February 19, 2016
T47D Cells Expressing Myeloperoxidase Are Able to Process, Traffic and Store the Mature Protein in Lysosomes: Studies in T47D Cells Reveal a Role for Cys319 in MPO Biosynthesis that Precedes Its Known Role in Inter-Molecular Disulfide Bond FormationRichard P Laura, David Dong, Wanda F Reynolds, et al.Journal of Lipid Research|April 28, 2006
Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G malesLawrence W Castellani, James J Chang, Xuping Wang, et al.Free Radical Biology & Medicine|June 9, 2019
Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairmentRichard A Maki, Michael Holzer, Khatereh Motamedchaboki, et al.NMR in Biomedicine|May 4, 2011
Parahydrogen-induced polarization (PHIP) hyperpolarized MR receptor imaging in vivo: a pilot study of 13C imaging of atheroma in micePratip Bhattacharya, Eduard Y Chekmenev, Wanda F Reynolds, et al.Pageof 5